background reduced bone mass density bmd frequent cystic fibrosis cf potentially genes cystic fibrosis transmembrane conductance regulator cftr gene contribute bone phenotype variability cf patients methods candidate genes likely associated bmd variability studied vitamin d receptor vdr gene estrogen receptor alpha esr1 calcitonin receptor calcr type alpha NUMBER collagen col1a1 gene complete bone cf evaluation obtained NUMBER subjects NUMBER m NUMBER f NUMBER normal bmd group NUMBER NUMBER osteopenic group NUMBER NUMBER osteoporotic group NUMBER results statistical difference groups age sex pancreatic status vertebral fractures biochemical markers weight body mass index bmi fev1 scored significantly worse groups lowest t score cftr mutations r1162x f508del frequent patients lower bmd p0044 p0071 significant difference distribution marker genotypes NUMBER groups defined according unadjusted adjusted bmi fev1 bmd t score significant correlation vdr calcr col1a1 gene polymorphisms reduced bmd values individual esr1 haplotype associated elevated levels haplotype associated lower values p000251 conclusions evidence genes study possible exception esr1 gene variants modulate bone phenotype cf pvuii xbai c u calcium t